5-carboxamidotryptamine has been researched along with glucagon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horisaka, K; Kimura, I; Sugimoto, Y; Takeuchi, N; Watanabe, Y; Yamada, J | 1 |
| Noma, T; Sugimoto, Y; Yamada, J; Yoshikawa, T | 1 |
2 other study(ies) available for 5-carboxamidotryptamine and glucagon
| Article | Year |
|---|---|
Peripherally administered serotonin induces hyperglucagonemia in mice.
Topics: Animals; Glucagon; Indoles; Injections, Intraperitoneal; Ketanserin; Male; Methysergide; Mice; Mice, Inbred Strains; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tropanes; Tropisetron | 1993 |
Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Glucose; Glucagon; Hyperglycemia; Insulin; Male; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasodilator Agents | 1998 |